« Previous
Next »
Archives of Physical Medicine and Rehabilitation
Volume 89, Issue 2
, Pages
237-243
, February 2008
Incidence of Fractures in a Cohort of Veterans With Chronic Multiple Sclerosis or Traumatic Spinal Cord Injury
-
Location of fracture by cause of SCD. Proportion of fractures for MS (n=219) and SCI (n=1519). NOTE. Overall difference in distribution of fractures was significant (Cochran-Mantel-Haenszel, P<.001).
Location of fracture by cause of SCD. Proportion of fractures for MS (n=219) and SCI (n=1519). NOTE. Overall difference in distribution of fractures was significant (Cochran-Mantel-Haenszel, P<.001). Abbreviations: Ext, extremity; Fem Sft Dist, femoral shaft and distal femur; Fx, fracture; Other, includes clavicle, scapula, and unclassifiable fractures; Prox Fem, proximal femur; Tib/Fib, tibia and fibula.
-
Fracture rates by cause and degree of impairment. Measure fracture rates per 100 patient-years at risk among the surviving members of our cohort stratified by degree of motor impairment and cause of SFracture rates by cause and degree of impairment. Measure fracture rates per 100 patient-years at risk among the surviving members of our cohort stratified by degree of motor impairment and cause of SCD. Abbreviation: Imp, impairment.
-
Time to first fracture by cause and degree of impairment. (A) Time to first fracture by degree of motor impairment. “Some” and “moderate” impairment had the shortest time to first fracture. (B) Time tTime to first fracture by cause and degree of impairment. (A) Time to first fracture by degree of motor impairment. “Some” and “moderate” impairment had the shortest time to first fracture. (B) Time to first fracture by cause of SCD. Those with trauma had a shorter time to fracture than those with MS.
Supported by the Center For the Study of Aging and Human Development.A commercial party having a direct financial interest in the results of the research supporting this article has conferred or will confer a financial benefit upon the author or one or more of the authors. Lyles has received financial support from Novartis, the Alliance for Better Bone Health, and Amgen; he is a consultant to Novartis, Procter & Gamble, Merck, Amgen, GTx, and Bone Medical Ltd; he holds U.S. patent 20050272707 (methods for preventing or reducing secondary fractures after hip fracture); and has a provisional patent application (medications kits and formulations for preventing, treating, or reducing secondary fractures after previous fracture).
PII: S0003-9993(07)01654-1
doi: 10.1016/j.apmr.2007.08.144
© 2008 American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Archives of Physical Medicine and Rehabilitation
Volume 89, Issue 2
, Pages
237-243
, February 2008
